Sustainable stocks are ready for a clean energy future and can deliver solid returns in all types of market environments.
Investor's Business Daily on MSN

Workiva Cl A Sees IBD RS Rating Rise To 73

On Friday, Workiva Cl A WK earned an upgrade to its Relative Strength (RS) Rating, from 70 to 73. Can You Really Time The ...
Inflammatory bowel disease (IBD) belongs to a broader category of health conditions known as immune-mediated inflammatory diseases (IMIDs). These disorders share a common characteristic: chronic ...
VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis. Their ...
Please provide your email address to receive an email when new articles are posted on . Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn’s disease, presents a complex ...
A new study highlights that children suffering from inflammatory bowel disease (IBD) are not meeting the daily recommended intake of calcium and vitamin D. The research, conducted at Great Ormond ...
US clinical-stage biotech Spyre Therapeutics on Wednesday announced the closing of its previously announced underwritten public offering of 17,094,594 shares of its common stock, including the full ...
New research conducted by an international consortium shows that IBD and related conditions are now spreading through developing regions in Africa, Asia, and Latin America. Inflammatory bowel disease, ...
Discovered at McMaster, the newly identified antibiotic presents a potential new therapy for individuals living with Crohn's ...
New York-based Immunai, a biotech that uses single-cell genomics and machine learning to discover and improve development of ...